Immunexpress

Last updated: August 22, 2024

Rolland Carlson, CEO
Rolland Carlson, CEO
USA | Funding: $67M (+)

Website: http://www.immunexpress.com/

Immunexpress, a molecular diagnostics company, developed a product pipeline to address the unmet clinical needs of sepsis patients, as well as the professional needs of clinicians, payers, and healthcare systems.